Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.

By R. Avery, J. Pearlman, D. Pieramici, M. Rabena, A. Castellarin, M. Nasir, Matthew J. Giust, R. Wendel, A. Patel. Ophthalmology (Rochester, Minn.), 2006

788 citations recorded by the source corpus.

Subfields: Ophthalmology, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/57fa892daf309c804380c68cc7e11e150eeb5f16

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Hartnett
2. J. Penn
3. Ruth B. Caldwell
4. R. W. Caldwell
5. A. Madan
6. M. Bartoli

Citations in the corpus

• Vascular endothelial growth factor in eye disease. (2008, background): “3.7 Targeting VEGF in Diabetic Retinopathy 3.7.1 Laser therapy—Laser photocoagulation is the recommended treatment for clinically significant DME or advanced PDR (for review, see Frank, 2002; Frank, 2004).”